Efficacy and safety of direct oral anticoagulants in older adults with atrial fibrillation: a prospective single-centre cohort study

被引：0
作者：
Filippo Catalani
Elena Campello
Giuseppina Occhipinti
Alessandro Zorzi
Marta Sartori
Bruno Micael Zanforlini
Alessandro Franchin
Paolo Simioni
Giuseppe Sergi
机构：
[1] Geriatric Unit,Department of Medicine
[2] University Hospital of Padova,General Medicine and Thrombotic and Hemorrhagic Diseases Unit, Department of Medicine
[3] University Hospital of Padova,undefined
来源：
Internal and Emergency Medicine | 2023年 / 18卷
关键词：
Heart disease; Atrial fibrillation; DOACs; Bleeding; Thrombosis; Elderly;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1941 / 1949
页数：8
相关论文
共 87 条
  • [1] Hindricks G(2021)2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 42 373-498
  • [2] Zoni-Berisso M(2014)Epidemiology of atrial fibrillation: European perspective Clin Epidemiol 213 6-213
  • [3] Lercari F(1991)Original contributions atrial fibrillation as an independent risk factor for stroke: the Framingham study Stroke 22 983-988
  • [4] Carazza T(2009)Dabigatran versus warfarin in patients with atrial fibrillation N Engl J Med 361 1139-1151
  • [5] Domenicucci S(2011)Rivaroxaban versus warfarin in nonvalvular atrial fibrillation N Engl J Med 365 883-891
  • [6] Wolf PA(2013)Edoxaban versus warfarin in patients with atrial fibrillation N Engl J Med 369 2093-2104
  • [7] Abbott RD(2011)Apixaban versus warfarin in patients with atrial fibrillation N Engl J Med 11 981-992
  • [8] Kannel WB(2014)Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials The Lancet 383 955-962
  • [9] Connolly SJ(2020)Direct oral anticoagulants in patients with inherited thrombophilia and venous thromboembolism: a prospective cohort study J Am Heart Assoc 9 23-1277
  • [10] Patel MR(2017)Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study BMJ 10 356-279
123456789